Telix Pharmaceuticals Limited
TLX
Jodie situation report
Telix Pharmaceuticals Limited's move is being confirmed by its market group.
TLX accounts for 3.7% of the group's measured movement across 6.7 effective names. raw member direction is mixed; 7 of 11 session-normalized paths align to the upside. Capital-flow agreement is 21%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
No material onset for TLX could be timestamped inside the aligned 5-minute window.
10 of 11 members in Quantum Technology are active. 0 of 1 disclosed connections are confirming.
- At least 8 of 11 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as BTGO begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.
Who this business touches
The relationships behind TLX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
LNTHLantheus Holdings, Inc.competitorFeb 26, 2026 ▾
“PYLARIFY currently competes with three commercially available Gallium-68-based PSMA PET imaging agents, two from Telix Pharmaceuticals Limited and one from Novartis AG and an F-18 PSMA PET imaging agent from Blue Earth Diagnostics Ltd.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TLX is currently a Participant in the organic co-movement group Quantum Technology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.